<SEC-DOCUMENT>0001104659-22-044286.txt : 20220408
<SEC-HEADER>0001104659-22-044286.hdr.sgml : 20220408
<ACCEPTANCE-DATETIME>20220408164045
ACCESSION NUMBER:		0001104659-22-044286
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20220406
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Material Modifications to Rights of Security Holders
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220408
DATE AS OF CHANGE:		20220408

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ROCKWELL MEDICAL, INC.
		CENTRAL INDEX KEY:			0001041024
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				383317208
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23661
		FILM NUMBER:		22817565

	BUSINESS ADDRESS:	
		STREET 1:		30142 WIXOM ROAD
		CITY:			WIXOM
		STATE:			MI
		ZIP:			48393
		BUSINESS PHONE:		8004493353

	MAIL ADDRESS:	
		STREET 1:		30142 WIXOM ROAD
		CITY:			WIXOM
		STATE:			MI
		ZIP:			48393

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ROCKWELL MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	20120530

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ROCKWELL MEDICAL, INC.
		DATE OF NAME CHANGE:	20120525

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ROCKWELL MEDICAL TECHNOLOGIES INC
		DATE OF NAME CHANGE:	19970722
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2212215d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:rmti="http://rockwellmed.com/20220406">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_03E_rmti_rockwellmed.com_20220406 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20220406_20220406 -->
<!-- Field: Set; Name: xdx; ID: xdx_05E_edei%2D%2DEntityCentralIndexKey_0001041024 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_050_edei%2D%2DCurrentFiscalYearEndDate_12/31 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2022-04-06to2022-04-06" name="dei:EntityCentralIndexKey">0001041024</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-04-06to2022-04-06" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2022-04-06to2022-04-06" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate">12/31</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="rmti-20220406.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2022-04-06to2022-04-06">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001041024</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-04-06</xbrli:startDate>
        <xbrli:endDate>2022-04-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WASHINGTON, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>FORM&#160;<span id="xdx_90B_edei--DocumentType_c20220406__20220406_zJ0uVFL0N81l"><ix:nonNumeric contextRef="From2022-04-06to2022-04-06" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section&#160;13 or 15(d)&#160;of</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>the Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"> <b>&#160;<span id="xdx_903_edei--DocumentPeriodEndDate_c20220406__20220406_zSqqhvZxNfRe"><ix:nonNumeric contextRef="From2022-04-06to2022-04-06" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">April 6, 2022</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Date of Report<br />
(Date of earliest event reported)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_907_edei--EntityRegistrantName_c20220406__20220406_z0oB9Z81live"><ix:nonNumeric contextRef="From2022-04-06to2022-04-06" name="dei:EntityRegistrantName">Rockwell Medical, Inc.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact name of registrant as specified in its
charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt; vertical-align: bottom; font-size: 10pt; text-align: center; width: 33%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_90E_edei--EntityIncorporationStateCountryCode_c20220406__20220406_zkbksIzDSI9k"><ix:nonNumeric contextRef="From2022-04-06to2022-04-06" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="padding: 1.5pt; vertical-align: bottom; font-size: 10pt; text-align: center; width: 34%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_902_edei--EntityFileNumber_c20220406__20220406_z6ZMmwT2v8le"><ix:nonNumeric contextRef="From2022-04-06to2022-04-06" name="dei:EntityFileNumber">000-23661</ix:nonNumeric></span></b></span></td>
    <td style="padding: 1.5pt; vertical-align: bottom; font-size: 10pt; text-align: center; width: 33%"><span style="font: 10pt Times New Roman, Times, Serif"><b><span id="xdx_908_edei--EntityTaxIdentificationNumber_c20220406__20220406_zd5KpkxQYy6b"><ix:nonNumeric contextRef="From2022-04-06to2022-04-06" name="dei:EntityTaxIdentificationNumber">38-3317208</ix:nonNumeric></span></b></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="padding: 1.5pt; vertical-align: top; text-align: center">(State or other jurisdiction <br />
    of incorporation)</td>
    <td style="padding: 1.5pt; vertical-align: top; font-size: 10pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission
    <br />
File Number)</span></td>
    <td style="padding: 1.5pt; vertical-align: top; text-align: center">(IRS Employer<br />
    Identification No.)</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_900_edei--EntityAddressAddressLine1_c20220406__20220406_zR6FZ7JOF4r9"><b><ix:nonNumeric contextRef="From2022-04-06to2022-04-06" name="dei:EntityAddressAddressLine1">30142
S. Wixom Road</ix:nonNumeric></b></span><b>, <span id="xdx_905_edei--EntityAddressCityOrTown_c20220406__20220406_z2rMOnODJVt"><ix:nonNumeric contextRef="From2022-04-06to2022-04-06" name="dei:EntityAddressCityOrTown">Wixom, <span id="xdx_904_edei--EntityAddressStateOrProvince_c20220406__20220406_ziqI4tWZiDRl"><ix:nonNumeric contextRef="From2022-04-06to2022-04-06" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">Michigan</ix:nonNumeric>
</span></ix:nonNumeric></span></b><b><span id="xdx_90A_edei--EntityAddressPostalZipCode_c20220406__20220406_zbkcNMrNtmgb"><ix:nonNumeric contextRef="From2022-04-06to2022-04-06" name="dei:EntityAddressPostalZipCode">48393</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of principal executive offices, including
Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>(<span id="xdx_906_edei--CityAreaCode_c20220406__20220406_zqjOkrfa6gh7"><ix:nonNumeric contextRef="From2022-04-06to2022-04-06" name="dei:CityAreaCode">248</ix:nonNumeric></span>) <span id="xdx_90C_edei--LocalPhoneNumber_c20220406__20220406_zhrcSLnmetS1"><ix:nonNumeric contextRef="From2022-04-06to2022-04-06" name="dei:LocalPhoneNumber">960-9009</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Registrant&#8217;s telephone number, including
area code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>N/A</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former name or former address, if changed since
last report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>



<p style="border-top: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Check the appropriate box below if the Form
8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.125in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_90A_edei--WrittenCommunications_c20220406__20220406_zyMKiQr93vU4"><ix:nonNumeric contextRef="From2022-04-06to2022-04-06" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Written
communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.125in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_90E_edei--SolicitingMaterial_c20220406__20220406_zDetvNDN29gb"><ix:nonNumeric contextRef="From2022-04-06to2022-04-06" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting
material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td>
</tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.125in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_909_edei--PreCommencementTenderOffer_c20220406__20220406_zxfI7uofkleb"><ix:nonNumeric contextRef="From2022-04-06to2022-04-06" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule&#160;14d-2(b)&#160;under the Exchange Act (17 CFR 240.14d-2(b))</span></td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.125in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Wingdings"><span id="xdx_90C_edei--PreCommencementIssuerTenderOffer_c20220406__20220406_zeYpq4wwoTBf"><ix:nonNumeric contextRef="From2022-04-06to2022-04-06" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></td><td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement
communications pursuant to Rule&#160;13e-4(c)&#160;under the Exchange Act (17 CFR 240.13e-4(c))</span></td>
</tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section&#160;12(b)&#160;of
the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 32%; text-align: center; padding-bottom: 1pt; padding-left: 1.5pt">Title&#160;of&#160;each&#160;class</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 32%; text-align: center; padding-bottom: 1pt; padding-left: 1.5pt">Trading&#160;<br />
Symbol (s)</td><td style="font: bold 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; width: 32%; text-align: center; padding-left: 1.5pt">Name&#160;of&#160;each&#160;exchange&#160;on&#160;which registered</td></tr>
<tr style="vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 1.5pt"><span id="xdx_904_edei--Security12bTitle_c20220406__20220406_zHvmxEN6UX6a"><ix:nonNumeric contextRef="From2022-04-06to2022-04-06" name="dei:Security12bTitle">Common Stock, par value $0.0001</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 1.5pt"><span id="xdx_904_edei--TradingSymbol_c20220406__20220406_zVdyuyosmWxd"><ix:nonNumeric contextRef="From2022-04-06to2022-04-06" name="dei:TradingSymbol">RMTI</ix:nonNumeric></span></td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; padding-left: 1.5pt"><span id="xdx_90B_edei--SecurityExchangeName_c20220406__20220406_z8b3ENqD2fJ1"><ix:nonNumeric contextRef="From2022-04-06to2022-04-06" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric> </span>Global Market</td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule&#160;405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule&#160;12b-2
of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Emerging
growth company <span style="font-family: Wingdings"><span id="xdx_909_edei--EntityEmergingGrowthCompany_c20220406__20220406_zO2n00X2CwS1"><ix:nonNumeric contextRef="From2022-04-06to2022-04-06" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for
complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a)&#160;of the Exchange Act.
</span><span style="font-family: Wingdings"><span style="font-family: Wingdings">&#168;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 10%; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Item 1.01</span></b></span></td>
    <td style="width: 90%; font-size: 10pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline">Entry into a Material Definitive Agreement.</span></b></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Amended Supply Agreement&#160;</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As previously reported, Rockwell Medical, Inc.
(the &#8220;Company&#8221;) has been working to renegotiate certain terms of its supply contracts with the Company&#8217;s two largest
customers in an effort to allow the Company to stabilize its concentrates business. On April 6, 2022, the Company and DaVita Inc. (&#8220;<b><i>DaVita</i></b>&#8221;)
entered into an amendment (the &#8220;<b><i>Amendment</i></b>&#8221;) to the Products Purchase Agreement, dated July 1, 2019 (the &#8220;<b><i>Supply
Agreement</i></b>&#8221;) under which the Company supplies DaVita with certain dialysis concentrates. Under the Amendment, the Company
and DaVita agreed to a price increase, effective May 1, 2022, as well as the pass-through of certain costs, determined on a quarterly
basis. Certain costs are subject to a cap. The Amendment will provide the Company with the potential to operate the concentrates business
profitably in the future, subject to cost containment activities to be undertaken by the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Amendment contains certain covenants with respect
to the Company&#8217;s ongoing operations, including a minimum cash covenant, and the requirement to raise additional capital by an outside
date. The Amendment also establishes a joint committee that will oversee certain efficiency and cost-savings activities to be undertaken
by the Company. Cost savings that are realized by the Company will be shared with DaVita in the manner set forth in the Amendment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Securities Purchase Agreement</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Also on April 6, 2022, the Company and DaVita entered
into a Securities Purchase Agreement (the &#8220;<b><i>SPA</i></b>&#8221;), pursuant to which the Company will issue up to $15 million
of preferred stock to DaVita. The Company will initially issue 7,500 shares of a newly designated series of preferred stock, which is
designated &#8220;Series X Convertible Preferred Stock&#8221; (the &#8220;<b><i>Series X Preferred Stock</i></b>&#8221;) for gross proceeds
of $7,500,000. The Company will issue to DaVita an additional 7,500 shares of Series X Preferred Stock in a second closing (the &#8220;<b><i>Second
Tranche</i></b>&#8221;) for an additional $7,500,000 if the Company raises additional capital by an outside date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Series X Preferred Stock will be issued for
a price $1,000 per share, subject to accretion at an interest rate of 1% per annum, compounded annually (the &#8220;<b><i>Face Amount</i></b>&#8221;).
If the Company&#8217;s common stock trades above $2.00 for a period of 30 calendar days, interest will thereafter cease to accrue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Series X Preferred Stock is convertible to
common stock at rate equal to the Face Amount, divided by a conversion price of $1.00 per share (subject to adjustment for stock splits,
reverse stock splits and similar recapitalization events). As a result, each share of Series X Preferred Stock will initially convert
into 1,000 shares of common stock. DaVita&#8217;s right to convert to common stock is subject to a beneficial ownership limitation, which
is initially set at 9.9% of the outstanding common stock, which limitation may be reset (not to exceed 19.9%) at DaVita&#8217;s option
and upon providing prior written notice to the Company. The preferred shares issued in the Second Tranche will have a lower conversion
price if the Company raises capital through the issuance of convertible preferred stock prior to the closing of the Second Tranche and
the conversion price of the securities sold in such preferred stock offerings is below $1.00 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Series X Preferred Stock is entitled to a liquidation
preference on a change of control equal to the greater of the Face Amount or the as-converted value of the underlying common stock. If
the Company sells its dialysis concentrates business while the Series X Preferred Stock remains outstanding, DaVita will have the right
to cause the Company to redeem the Series X Preferred Stock for a purchase price equal to the Face Amount, with the aggregate purchase
price not to exceed the sale proceeds, net of repayment of any indebtedness. Additionally, following effectiveness of the resale registration
statement, the Company has the right to redeem the Series X Preferred Stock on 30 days&#8217; notice at a price equal to the greater of
the Face Amount or the as-converted value of the underlying common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Series X Preferred Stock is generally non-voting.
However, the approval of the holders of a majority of the Series X Preferred Stock is required for the payment of dividends, designation
of a senior preferred security, changes to terms of the Series X Preferred Stock or the incurrence of indebtedness, subject to certain
exceptions for permitted indebtedness.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company has agreed to file a resale registration
statement on Form S-3 for the resale of the common stock underlying the Series X Preferred Stock (the &#8220;<b><i>Conversion Shares</i></b>&#8221;).
DaVita has agreed to a customary lock-up on the Conversion Shares for a period of 180 days from the initial closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The foregoing descriptions of the Amendment and
the SPA do not purport to be complete and are qualified in their entirety by reference to the complete text of such agreements, which
the Company intends to file with its quarterly report on Form 10-Q for the quarter ended March 31, 2022.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 10%"><span style="text-decoration: underline">Item&#160;3.02</span>&#160;&#160;&#160;&#160;&#160;&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 90%"><span style="text-decoration: underline">Unregistered Sales of Equity Securities.</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 58.5pt; text-indent: -58.5pt"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">The information set forth in Item 1.01 above regarding
the issuance of the Series X Preferred Stock is incorporated by reference into this Item 3.02. The offering and sale of the Series X Preferred
Stock was exempt from registration under Section 4(a)(2) of the Securities Act of 1933, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 10%"><span style="text-decoration: underline">Item&#160;3.03</span>&#160;&#160;&#160;&#160;&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 90%"><span style="text-decoration: underline">Material Modification to Rights of Security Holders.</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The
information set forth in Item 1.01 above regarding the designation of the Series X Preferred Stock under the Company&#8217;s Amended and
Restated Certificate of Incorporation is incorporated by reference into this Item&#160;3.03. A copy of the </span>Certificate of Designation
of Preferences, Rights and Limitations of Series X Convertible Preferred Stock is filed herewith as Exhibit 3.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"><tr style="vertical-align: top">
<td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif"><b><span style="text-decoration: underline">Item 5.03</span></b></span></td><td style="width: 90%"><b><span style="text-decoration: underline">Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year</span></b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The
information set forth in Item 1.01 above regarding the designation of the Series X Preferred Stock under the Company&#8217;s Amended and
Restated Certificate of Incorporation is incorporated by reference into this Item&#160;5.03. A copy of the </span>Certificate of Designation
of Preferences, Rights and Limitations of Series X Convertible Preferred Stock is filed herewith as Exhibit 3.1.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 10%"><span style="text-decoration: underline">Item&#160;9.01</span>&#160;&#160;&#160;</td>
    <td style="font: bold 10pt Times New Roman, Times, Serif; width: 90%"><span style="text-decoration: underline">Financial Statements and Exhibits.</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&#160;<i>Exhibits&#160;&#160;&#160;&#160;&#160;&#160;&#160;</i>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">EXHIBIT&#160;INDEX</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
<td style="border-bottom: black 1pt solid; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
<td style="text-align: center; width: 2%">&#160;</td>
<td style="border-bottom: black 1pt solid; text-align: center; width: 88%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
<tr>
<td style="vertical-align: top"><a href="tm2212215d1_ex3-1.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></a></td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top"><a href="tm2212215d1_ex3-1.htm">Certificate of Designation of Preferences, Rights and Limitations of Series X Convertible Preferred Stock</a></td></tr>
<tr>
<td style="vertical-align: top">&#160;</td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top">&#160;</td></tr>
<tr>
<td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File, formatted in INline XBRL and included as Exhibit 101.</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline">SIGNATURE</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr>
<td style="vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ROCKWELL MEDICAL, INC.</b></span></td></tr>
<tr>
<td style="vertical-align: bottom">&#160;</td>
<td colspan="2" style="vertical-align: bottom">&#160;</td></tr>
<tr>
<td style="vertical-align: top; text-align: justify; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date: April 8, 2022 </span></td>
<td style="vertical-align: top; text-align: justify; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
<td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: justify; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: none">/s/ Russell </span>Skibsted</span></td></tr>
<tr>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </span></td>
<td style="vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Russell Skibsted</span></td></tr>
<tr>
<td style="vertical-align: bottom">&#160;</td>
<td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </span></td>
<td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwkAMhU/QO4RZi05/dNGdFhWxihQRt0ObymA7KZnx70je0rFFDIGQvPflCTESa1rpBhnOiyKHI7ZdoxxCgTUymhK9I9tsU/CzwIu2jpVx/foDM/IMemY6jkt/7513bbFKQc4mMplEEmSSxiHMdyL46hmZWldonFYNKFPBgaljjU7xa/hwVE8y1L76pBOy1WRSCMdykN8QyTCCPd3Vg/hqIc8zEYz6CsSa6dZ9Y27WUQvLBlufZQf038EH0vxJBg== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>tm2212215d1_ex3-1.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 3.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ROCKWELL MEDICAL,&nbsp;INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>CERTIFICATE OF DESIGNATION
OF PREFERENCES,</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>RIGHTS AND LIMITATIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>SERIES X CONVERTIBLE PREFERRED STOCK</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">PURSUANT TO SECTION&nbsp;151
OF THE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">DELAWARE GENERAL CORPORATION LAW</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>ROCKWELL
MEDICAL,&nbsp;INC.</B></FONT>, a Delaware corporation (the &ldquo;<B><U>Corporation</U></B>&rdquo;), in accordance with the provisions
of Section&nbsp;103 of the Delaware General Corporation Law (the &ldquo;<B><U>DGCL</U></B>&rdquo;) does hereby certify that, in accordance
with Sections 141(c)&nbsp;and 151 of the DGCL, the following resolution was duly adopted by a committee of the Board of Directors of the
Corporation acting upon authority delegated by the Board of Directors, on April&nbsp;6, 2022:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>RESOLVED</B></FONT>,
pursuant to authority expressly set forth in the Amended and Restated Certificate of Incorporation of the Corporation, as amended (the
 &ldquo;<B><U>Certificate of Incorporation</U></B>&rdquo;), the issuance of a series of Preferred Stock designated as the Series&nbsp;X
Convertible Preferred Stock, par value $0.0001 per share, of the Corporation is hereby authorized and the designation, number of shares,
powers, preferences, rights, qualifications, limitations and restrictions thereof (in addition to any provisions set forth in the Certificate
of Incorporation that are applicable to the Preferred Stock of all classes and series) are hereby fixed, and the Certificate of Designation
of Preferences, Rights and Limitations of Series&nbsp;X Convertible Preferred Stock is hereby approved as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SERIES X CONVERTIBLE PREFERRED STOCK</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Section&nbsp;1</U></FONT>.&#8239;&#8239;&#8239;&#8239;&#8239;
<U>Definitions</U>. For the purposes hereof, the following terms shall have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Affiliate</U></B>&rdquo;</FONT>
means any person or entity that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a person or entity, as such terms are used in and construed under Rule&nbsp;144 under the Securities Act of 1933. With respect
to a Holder, any investment fund or managed account that is managed on a discretionary basis by the same investment manager as such Holder
will be deemed to be an Affiliate of such Holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Alternate
Consideration</U></B>&rdquo;</FONT> shall have the meaning set forth in Section&nbsp;7(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Beneficial
Ownership Limitation</U></B>&rdquo;</FONT> shall have the meaning set forth in Section&nbsp;6(c).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Business
Day</U></B>&rdquo;</FONT> means any day except Saturday, Sunday, any day which shall be a federal legal holiday in the United States or
any day on which banking institutions in the State of New York are authorized or required by law or other governmental action to close.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Buy-In</U></B>&rdquo;</FONT>
shall have the meaning set forth in Section&nbsp;6(d)(iii).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Closing
Sale Price</U></B>&rdquo;</FONT> means, for any security as of any date, the last closing trade price for such security prior to 4:00
p.m., New York City time, on the principal securities exchange or trading market where such security is listed or traded, as reported
by Bloomberg, L.P. (or an equivalent, reliable reporting service mutually acceptable to and hereafter designated by Holders of a majority
of the then-outstanding Series&nbsp;X Preferred Stock and the Corporation), or if the foregoing do not apply, the last trade price of
such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg, L.P., or, if
no last trade price is reported for such security by Bloomberg, L.P., the average of the bid prices of any market makers for such security
as reported on the OTC Pink Market by OTC Markets Group,&nbsp;Inc. If the Closing Sale Price cannot be calculated for a security on a
particular date on any of the foregoing bases, the Closing Sale Price of such security on such date shall be the fair market value as
determined in good faith by the Board of Directors of the Corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Commission</U></B>&rdquo;</FONT>
means the Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Common
Stock</U></B>&rdquo;</FONT> means the Corporation&rsquo;s common stock, par value $0.0001 per share, and stock of any other class of securities
into which such securities may hereafter be reclassified or changed into.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Conversion
Date</U></B>&rdquo;</FONT> shall have the meaning set forth in Section&nbsp;6(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Conversion
Price</U></B>&rdquo;</FONT> shall mean $1.00, as adjusted pursuant to paragraph 7 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Conversion
Ratio</U></B>&rdquo;</FONT> shall have the meaning set forth in Section&nbsp;6(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Conversion
Shares</U></B>&rdquo;</FONT> means, collectively, the shares of Common Stock issuable upon conversion of the shares of Series&nbsp;X Preferred
Stock in accordance with the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&ldquo;<B><U>Deemed Liquidation Event</U></B>&rdquo;
means the occurrence of any of the following events, unless the holders of at least a majority of the outstanding shares of Series&nbsp;X
Preferred Stock otherwise by written notice sent to the Corporation at least 10 calendar days prior to the effective date of any such
event:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">a
merger or consolidation in which:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
Corporation is a constituent party; or</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">a
subsidiary of the Corporation is a constituent party and the Corporation issues shares of its capital stock pursuant to such merger or
consolidation,</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">except any such merger or consolidation involving the Corporation or
a subsidiary in which the shares of capital stock of the Corporation outstanding immediately prior to such merger or consolidation continue
to represent, or are converted into or exchanged for shares of capital stock that represent, immediately following such merger or consolidation,
at least a majority of the capital stock of (1)&nbsp;the surviving or resulting corporation; or (2)&nbsp;if the surviving or resulting
corporation is a wholly owned subsidiary of another corporation immediately following such merger or consolidation, the parent corporation
of such surviving or resulting corporation; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt">(1)&nbsp;the
sale, lease, transfer, exclusive license or other disposition, in a single transaction or series of related transactions, by the Corporation
or any subsidiary of the Corporation of all or substantially all the assets of the Corporation and its subsidiaries taken as a whole,
or (2)&nbsp;the sale or disposition (whether by merger, consolidation or otherwise, and whether in a single transaction or a series of
related transactions) of one or more subsidiaries of the Corporation if substantially all of the assets of the Corporation and its subsidiaries
taken as a whole are held by such subsidiary or subsidiaries, except where such sale, lease, transfer, exclusive license or other disposition
is to a wholly owned subsidiary of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>DGCL</U></B>&rdquo;</FONT>
shall mean the Delaware General Corporation Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Distributions</U></B>&rdquo;</FONT>
shall have the meaning set forth in Section&nbsp;5(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>DTC</U></B>&rdquo;</FONT>
shall have the meaning set forth in Section&nbsp;6(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>DWAC
Delivery</U></B>&rdquo;</FONT> shall have the meaning set forth in Section&nbsp;6(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Exchange
Act</U></B>&rdquo;</FONT> means the Securities Exchange Act of 1934, as amended, and the rules&nbsp;and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Fundamental
Transaction</U></B>&rdquo;</FONT> shall have the meaning set forth in Section&nbsp;7(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Holder</U></B>&rdquo;</FONT>
means any holder of Series&nbsp;X Preferred Stock.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Junior
Securities</U></B>&rdquo;</FONT> shall have the meaning set forth in Section&nbsp;5(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Notice
of Conversion</U></B>&rdquo;</FONT> shall have the meaning set forth in Section&nbsp;6(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Parity
Securities</U></B>&rdquo;</FONT> shall have the meaning set forth in Section&nbsp;5(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Person</U></B>&rdquo;</FONT>
means any individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Senior
Securities</U></B>&rdquo;</FONT> shall have the meaning set forth in Section&nbsp;5(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Series&nbsp;X
Preferred Stock</U></B>&rdquo;</FONT> shall have the meaning set forth in Section&nbsp;2(a).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Series&nbsp;X
Preferred Stock Register</U></B>&rdquo;</FONT> shall have the meaning set forth in Section&nbsp;2(b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Share
Delivery Date</U></B>&rdquo;</FONT> shall have the meaning set forth in Section&nbsp;6(d)(i).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Stated
Value</U></B>&rdquo;</FONT> shall mean $1,000 per share as of the date of initial issuance of such share, which amount shall increase
at a rate of 1% per annum, compounding annually from the initial issuance date. In the event that the closing price of the Corporation&rsquo;s
common stock is above $2.00 (adjusted for stock splits and similar recapitalization events) for at least 30 consecutive trading days,
then the foregoing accrual shall thereafter cease.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">&ldquo;<B><U>Trading
Day</U></B>&rdquo;</FONT> means a day on which the Common Stock is traded for any period on the principal securities exchange or if the
Common Stock is not traded on a principal securities exchange, on a day that the Common Stock is traded on another securities market on
which the Common Stock is then being traded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Section&nbsp;2</U></FONT>.
 &#8239;&#8239;&#8239;&#8239;&#8239;<U>Designation, Amount and Par Value; Assignment</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
series of preferred stock designated by this Certificate of Designation shall be designated as the Corporation&rsquo;s Series&nbsp;X Convertible
Preferred Stock (the &ldquo;<B><U>Series&nbsp;X Preferred Stock</U></B>&rdquo;) and the number of shares so designated shall be 15,000.
Each share of Series&nbsp;X Preferred Stock shall have a par value of $0.0001 per share.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Corporation shall register shares of the Series&nbsp;X Preferred Stock, upon records to be maintained by the Corporation for that purpose
(the &ldquo;<B><U>Series&nbsp;X Preferred Stock Register</U></B>&rdquo;), in the name of the Holders thereof from time to time. The Corporation
may deem and treat the registered Holder of shares of Series&nbsp;X Preferred Stock as the absolute owner thereof for the purpose of any
conversion thereof and for all other purposes. Shares of Series&nbsp;X Preferred Stock may be issued solely in book-entry form or, if
requested by any Holder, such Holder&rsquo;s shares may be issued in certificated form. The Corporation shall register the transfer of
any shares of Series&nbsp;X Preferred Stock in the Series&nbsp;X Preferred Stock Register, upon surrender of the certificates (if applicable)
evidencing such shares to be transferred, duly endorsed by the Holder thereof, to the Corporation at its address specified herein. Upon
any such registration or transfer, a new certificate evidencing the shares of Series&nbsp;X Preferred Stock so transferred shall be issued
to the transferee and a new certificate evidencing the remaining portion of the shares not so transferred, if any, shall be issued to
the transferring Holder, in each case, within three Business Days. The provisions of this Certificate of Designation are intended to be
for the benefit of all Holders from time to time and shall be enforceable by any such Holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&nbsp;3</U></FONT><FONT STYLE="font-size: 10pt">.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Dividends</U>.
Holders shall be entitled to receive, and the Corporation shall pay, dividends on shares of the Series&nbsp;X Preferred Stock equal (on
an as-if-converted-to-Common-Stock basis, without regard to the Beneficial Ownership Limitation) to and in the same form, and in the same
manner, as dividends (other than dividends in the form of Common Stock) actually paid on shares of the Common Stock when, as and if such
dividends (other than dividends in the form of Common Stock) are paid on shares of the Common Stock. Other than as set forth in the previous
sentence, no other dividends shall be paid on shares of Series&nbsp;X Preferred Stock, and the Corporation shall pay no dividends (other
than dividends in the form of Common Stock) on shares of the Common Stock unless it simultaneously complies with the previous sentence.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&nbsp;4</U></FONT><FONT STYLE="font-size: 10pt">.&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<U>Voting
Rights</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Solely
for purposes of determining the presence of a quorum at any meeting of the stockholders of the Corporation at which the shares of Series&nbsp;X
Preferred Stock are entitled to vote, the number of shares of Series&nbsp;X Preferred Stock and votes represented by such shares shall
be counted on an as converted to Common Stock basis, disregarding, for such purposes, any limitations on conversion set forth herein.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(b)&#8239;&#8239;&#8239;As long as at least 3,750 shares of
Series&nbsp;X Preferred Stock are outstanding, the Corporation shall not, without the affirmative vote of the Holders of a majority of
the then outstanding shares of the Series&nbsp;X Preferred Stock, take any of the following actions: (i)&nbsp;alter or change adversely
the powers, preferences or rights given to the Series&nbsp;X Preferred Stock or alter or amend this Certificate of Designation, (ii)&nbsp;amend
the Certificate of Incorporation or other charter documents in a manner that adversely affects any rights of the Holders, (iii)&nbsp;increase
the number of authorized shares of Series&nbsp;X Preferred Stock, (iv)&nbsp;create, or authorize the creation of, or issue or obligate
itself to issue shares of, or reclassify, any capital stock of the Corporation (or securities convertible into or exercisable for capital
stock of the Corporation) unless the same ranks junior or pari passu to the Series&nbsp;X Preferred Stock with respect to its rights,
preferences and privileges (including without limitation any Senior Securities), (v)&nbsp;declare or pay any dividends payable in cash
or property of the Corporation (but not shares of capital stock), or (vi)&nbsp;enter into any agreement with respect to any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Except
as otherwise provided herein or as otherwise required by the DGCL, the Series&nbsp;X Preferred Stock shall have no voting rights.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Section&nbsp;5</U></FONT>.&#8239;&#8239;&#8239;&#8239;&#8239;
<U>Rank; Liquidation</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)&#8239;&#8239;&#8239;</FONT><FONT STYLE="font-size: 10pt">The
Series&nbsp;X Preferred Stock shall rank: (i)&nbsp;senior to all of the Common Stock; (ii)&nbsp;senior to any class or series of capital
stock of the Corporation hereafter created specifically ranking by its terms junior to any Series&nbsp;X Preferred Stock (&ldquo;<B><U>Junior
Securities</U></B>&rdquo;); (iii)&nbsp;on parity with any class or series of capital stock of the Corporation hereafter created specifically
ranking by its terms on parity with the Series&nbsp;X Preferred Stock (together with the Series&nbsp;X Preferred Stock, the &ldquo;<B><U>Parity
Securities</U></B>&rdquo;); and (iv)&nbsp;junior to any class or series of capital stock of the Corporation hereafter created specifically
ranking by its terms senior to any Series&nbsp;X Preferred Stock (&ldquo;<B><U>Senior Securities</U></B>&rdquo;), in each case, as to
distributions of assets upon liquidation, dissolution or winding up of the Corporation, whether voluntarily or involuntarily (all such
distributions being referred to collectively as &ldquo;<B><U>Distributions</U></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">Subject
to the prior and superior rights of the holders of any Senior Securities of the Corporation, upon any liquidation, dissolution or winding
up of the Corporation, whether voluntary or involuntary (collectively, a &ldquo;<B><U>Liquidation Event</U></B>&rdquo;) or Deemed Liquidation
Event, each holder of shares of Series&nbsp;X Preferred Stock shall be entitled to receive in respect of one share of Series&nbsp;X Preferred
Stock, in preference to any distributions of any of the assets or surplus funds of the Corporation available for distribution to its stockholders
or other consideration payable to stockholders, to the holders of the Common Stock and Junior Securities, and <I>pari passu</I> with any
distribution to the holders of Parity Securities, an amount equal to the greater of: (i)&nbsp;the Stated Value as of such date, plus any
dividends declared but unpaid on such shares, or (ii)&nbsp;the amount that would be paid on an as-converted basis (without regard to the
conversion limits set forth in Section&nbsp;6(c)). If, upon any Liquidation Event or Deemed Liquidation Event, the assets of the Corporation
shall be insufficient to pay the holders of shares of the Series&nbsp;X Preferred Stock the amount required under clause (i)&nbsp;of the
preceding sentence, then all remaining assets of the Corporation or consideration payable to stockholders shall be distributed ratably
to holders of the shares of the Series&nbsp;X Preferred Stock and Parity Securities.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
amount deemed paid or distributed to the holders of capital stock of the Corporation upon any Liquidation Event or Deemed Liquidation
Event shall be the cash or the value of the property, rights or securities to be paid or distributed to such holders pursuant to such
Liquidation Event or Deemed Liquidation Event. The value of such property, rights or securities shall be determined in good faith by the
Board of Directors of the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">The
Corporation shall cause to be delivered to each Holder, at its last address as it shall appear upon the stock books of the Corporation,
written notice of any Liquidation Event or Deemed Liquidation Event at least 30 calendar days prior to the date on which such Liquidation
Event or Deemed Liquidation Event is expected to become effective or close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><U>Section&nbsp;6</U></FONT>.&#8239;&#8239;&#8239;&#8239;&#8239;
<U>Conversion</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Conversions
at Option of Holder</U>. Each share of Series&nbsp;X Preferred Stock shall be convertible at any time at the option of the Holder thereof,
into a number of shares of Common Stock equal to the Conversion Ratio. Holders shall effect conversions by providing the Corporation with
the form of conversion notice attached hereto as <B><U>Annex&nbsp;A</U></B> (a &ldquo;<B><U>Notice of Conversion</U></B>&rdquo;), duly
completed and executed. Other than a conversion following a Fundamental Transaction or following a notice provided for under Section&nbsp;7(d)(ii)&nbsp;hereof,
the Notice of Conversion must specify at least a number of shares of Series&nbsp;X Preferred Stock to be converted equal to the lesser
of (x)&nbsp;100 shares (such number subject to appropriate adjustment following the occurrence of an event specified in Section&nbsp;7(a)&nbsp;hereof)
and (y)&nbsp;the number of shares of Series&nbsp;X Preferred Stock then held by the Holder. Provided the Corporation&rsquo;s transfer
agent is participating in the Depository Trust Company (&ldquo;<B><U>DTC</U></B>&rdquo;) Fast Automated Securities Transfer program, the
Notice of Conversion may specify, at the Holder&rsquo;s election, whether the applicable Conversion Shares shall be credited to the account
of the Holder&rsquo;s prime broker with DTC through its Deposit Withdrawal Agent Commission system (a &ldquo;<B><U>DWAC Delivery</U></B>&rdquo;).
The &ldquo;<B><U>Conversion Date</U></B>&rdquo;, or the date on which a conversion shall be deemed effective, shall be defined as the
Trading Day that the Notice of Conversion, completed and executed, is sent by facsimile or email to, and received during regular business
hours by, the Corporation; provided that the original certificate(s)&nbsp;(if any) representing such shares of Series&nbsp;X Preferred
Stock being converted, duly endorsed, and the accompanying Notice of Conversion, are received by the Corporation within two Trading Days
thereafter. In all other cases, the Conversion Date shall be defined as the Trading Day on which the original shares of Series&nbsp;X
Preferred Stock being converted, duly endorsed, and the accompanying Notice of Conversion, are received by the Corporation. The calculations
set forth in the Notice of Conversion shall control in the absence of manifest or mathematical error.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Conversion
Ratio</U>. The &ldquo;<B><U>Conversion Ratio</U></B>&rdquo; for each share of Series&nbsp;X Preferred Stock shall be equal to the Stated
Value divided by the Conversion Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Beneficial
Ownership Limitation</U>. Notwithstanding anything herein to the contrary, the Corporation shall not effect any conversion of the Series&nbsp;X
Preferred Stock, and a Holder shall not have the right to convert any portion of the Series&nbsp;X Preferred Stock, to the extent that,
after giving effect to an attempted conversion set forth on an applicable Notice of Conversion, such Holder (together with such Holder&rsquo;s
Affiliates, and any other Person whose beneficial ownership of Common Stock would be aggregated with the Holder&rsquo;s for purposes of
Section&nbsp;13(d)&nbsp;or Section&nbsp;16 of the Exchange Act and the applicable regulations of the Commission, including any &ldquo;group&rdquo;
of which the Holder is a member (the foregoing, &ldquo;<B><U>Attribution Parties</U></B>&rdquo;)) would beneficially own a number of shares
of Common Stock in excess of the Beneficial Ownership Limitation (as defined below). For purposes of the foregoing sentence, the number
of shares of Common Stock beneficially owned by such Holder and its Attribution Parties shall include the number of shares of Common Stock
issuable upon conversion of the Series&nbsp;X Preferred Stock subject to the Notice of Conversion with respect to which such determination
is being made, but shall exclude the number of shares of Common Stock which are issuable upon (A)&nbsp;conversion of the remaining, unconverted
Series&nbsp;X Preferred Stock beneficially owned by such Holder or any of its Attribution Parties, and (B)&nbsp;exercise or conversion
of the unexercised or unconverted portion of any other securities of the Corporation (including any warrants) beneficially owned by such
Holder or any of its Attribution Parties that are subject to a limitation on conversion or exercise similar to the limitation contained
herein. For purposes of this Section&nbsp;6(c), beneficial ownership shall be calculated in accordance with Section&nbsp;13(d)&nbsp;of
the Exchange Act and the applicable regulations of the Commission. In addition, for purposes hereof, &ldquo;group&rdquo; has the meaning
set forth in Section&nbsp;13(d)&nbsp;of the Exchange Act and the applicable regulations of the Commission. For purposes of this Section&nbsp;6(c),
in determining the number of outstanding shares of Common Stock, a Holder may rely on the number of outstanding shares of Common Stock
as stated in the most recent of the following: (A)&nbsp;the Corporation&rsquo;s most recent periodic or annual filing with the Commission,
as the case may be, (B)&nbsp;a more recent public announcement by the Corporation that is filed with the Commission, or (C)&nbsp;a more
recent notice by the Corporation or the Corporation&rsquo;s transfer agent to the Holder setting forth the number of shares of Common
Stock then outstanding. Upon the written request of a Holder (which may be by email), the Corporation shall, within two Trading Days thereof,
confirm in writing to such Holder (which may be via email) the number of shares of Common Stock then outstanding. In any case, the number
of outstanding shares of Common Stock shall be determined after giving effect to any actual conversion or exercise of securities of the
Corporation, including shares of Series&nbsp;X Preferred Stock, by such Holder or its Attribution Parties since the date as of which such
number of outstanding shares of Common Stock was last publicly reported or confirmed to the Holder. The &ldquo;<B><U>Beneficial Ownership
Limitation</U></B>&rdquo; shall initially be 9.9% of the number of shares of the Common Stock outstanding immediately after giving effect
to the issuance of shares of Common Stock pursuant to such Notice of Conversion (to the extent permitted pursuant to this Section&nbsp;6(c)).
The Corporation shall be entitled to rely on representations made to it by the Holder in any Notice of Conversion regarding its Beneficial
Ownership Limitation. Notwithstanding the foregoing, by written notice to the Corporation, which will not be effective until the sixty-first
(61<SUP>st</SUP>) day after such notice is delivered to the Corporation in the case of an increase in the Beneficial Ownership Limitation,
the Holder may reset the Beneficial Ownership Limitation percentage to a higher or lower percentage, not to exceed 19.9% of the number
of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock pursuant to such Notice
of Conversion. Upon such a change by a Holder of the Beneficial Ownership Limitation, the Beneficial Ownership Limitation may not be subsequently
changed by such Holder without first providing the minimum notice required by this Section&nbsp;6(c)&nbsp;with respect to the subsequent
change. Notwithstanding the foregoing, at any time following notice of a Fundamental Transaction, the Holder may waive and/or change the
Beneficial Ownership Limitation effective immediately upon written notice to the Corporation and may reinstitute a Beneficial Ownership
Limitation at any time thereafter effective immediately upon written notice to the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Mechanics
of Conversion</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Delivery
of Certificate or Electronic Issuance Upon Conversion</U>. Not later than two Trading Days after the applicable Conversion Date, or if
the Holder requests the issuance of physical certificate(s), two Trading Days after receipt by the Corporation of the original certificate(s)&nbsp;representing
such shares of Series&nbsp;X Preferred Stock being converted, duly endorsed, and the accompanying Notice of Conversion (the &ldquo;<B><U>Share
Delivery Date</U></B>&rdquo;), the Corporation shall (a)&nbsp;deliver, or cause to be delivered, to the converting Holder a physical certificate
or certificates representing the number of Conversion Shares being acquired upon the conversion of shares of Series&nbsp;X Preferred Stock,
or (b)&nbsp;in the case of a DWAC Delivery (if so requested by the Holder), electronically transfer such Conversion Shares by crediting
the account of the Holder&rsquo;s prime broker with DTC through its DWAC system. If in the case of any Notice of Conversion such certificate
or certificates are not delivered to or as directed by or, in the case of a DWAC Delivery, such shares are not electronically delivered
to or as directed by, the applicable Holder by the Share Delivery Date, the applicable Holder shall be entitled to elect to rescind such
Notice of Conversion by written notice to the Corporation at any time on or before its receipt of such certificate or certificates for
Conversion Shares or electronic receipt of such shares, as applicable, in which event the Corporation shall promptly return to such Holder
any original Series&nbsp;X Preferred Stock certificate delivered to the Corporation and such Holder shall promptly return to the Corporation
any Common Stock certificates or otherwise direct the return of any shares of Common Stock delivered to the Holder through the DWAC system,
representing the shares of Series&nbsp;X Preferred Stock unsuccessfully tendered for conversion to the Corporation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Obligation
Absolute</U>. Subject to Section&nbsp;6(c)&nbsp;hereof and subject to Holder&rsquo;s right to rescind a Notice of Conversion pursuant
to Section&nbsp;6(d)(i)&nbsp;above, the Corporation&rsquo;s obligation to issue and deliver the Conversion Shares upon conversion of Series&nbsp;X
Preferred Stock in accordance with the terms hereof are absolute and unconditional, irrespective of any action or inaction by a Holder
to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any Person or any
action to enforce the same, or any setoff, counterclaim, recoupment, limitation or termination, or any breach or alleged breach by such
Holder or any other Person of any obligation to the Corporation or any violation or alleged violation of law by such Holder or any other
Person, and irrespective of any other circumstance which might otherwise limit such obligation of the Corporation to such Holder in connection
with the issuance of such Conversion Shares. Subject to Section&nbsp;6(c)&nbsp;hereof and subject to Holder&rsquo;s right to rescind a
Notice of Conversion pursuant to Section&nbsp;6(d)(i)&nbsp;above, in the event a Holder shall elect to convert any or all of its Series&nbsp;X
Preferred Stock, the Corporation may not refuse conversion based on any claim that such Holder or anyone associated or affiliated with
such Holder has been engaged in any violation of law, agreement or for any other reason, unless an injunction from a court, on notice
to Holder, restraining and/or enjoining conversion of all or part of the Series&nbsp;X Preferred Stock of such Holder shall have been
sought and obtained by the Corporation, and the Corporation posts a surety bond for the benefit of such Holder in the amount of 150% of
the value of the Conversion Shares into which would be converted the Series&nbsp;X Preferred Stock which is subject to such injunction,
which bond shall remain in effect until the completion of arbitration/litigation of the underlying dispute and the proceeds of which shall
be payable to such Holder to the extent it obtains judgment. In the absence of such injunction, the Corporation shall, subject to Section&nbsp;6(c)&nbsp;hereof
and subject to Holder&rsquo;s right to rescind a Notice of Conversion pursuant to Section&nbsp;6(d)(i)&nbsp;above, issue Conversion Shares
upon a properly noticed conversion.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Compensation
for Buy-In on Failure to Timely Deliver Certificates Upon Conversion</U>. If the Corporation fails to deliver to a Holder the applicable
certificate or certificates or to effect a DWAC Delivery, as applicable, by the Share Delivery Date pursuant to Section&nbsp;6(d)(i)&nbsp;(other
than a failure caused by incorrect or incomplete information provided by Holder to the Corporation), and if after such Share Delivery
Date such Holder is required by its brokerage firm to purchase (in an open market transaction or otherwise), or the Holder&rsquo;s brokerage
firm otherwise purchases, shares of Common Stock to deliver in satisfaction of a sale by such Holder of the Conversion Shares which such
Holder was entitled to receive upon the conversion relating to such Share Delivery Date (a &ldquo;<B><U>Buy-In</U></B>&rdquo;), then the
Corporation shall (A)&nbsp;pay in cash to such Holder (in addition to any other remedies available to or elected by such Holder) the amount
by which (x)&nbsp;such Holder&rsquo;s total purchase price (including any brokerage commissions) for the shares of Common Stock so purchased
exceeds (y)&nbsp;the product of (1)&nbsp;the aggregate number of shares of Common Stock that such Holder was entitled to receive from
the conversion at issue multiplied by (2)&nbsp;the actual sale price at which the sell order giving rise to such purchase obligation was
executed (including any brokerage commissions) and (B)&nbsp;at the option of such Holder, either reissue (if surrendered) the shares of
Series&nbsp;X Preferred Stock equal to the number of shares of Series&nbsp;X Preferred Stock submitted for conversion or deliver to such
Holder the number of shares of Common Stock that would have been issued if the Corporation had timely complied with its delivery requirements
under Section&nbsp;6(d)(i). For example, if a Holder purchases shares of Common Stock having a total purchase price of $11,000 to cover
a Buy-In with respect to an attempted conversion of shares of Series&nbsp;X Preferred Stock with respect to which the actual sale price
(including any brokerage commissions) giving rise to such purchase obligation was a total of $10,000 under clause (A)&nbsp;of the immediately
preceding sentence, the Corporation shall be required to pay such Holder $1,000. The Holder shall provide the Corporation written notice,
within two Trading Days after the occurrence of a Buy-In, indicating the amounts payable to such Holder in respect of such Buy-In together
with applicable confirmations and other evidence reasonably requested by the Corporation. Nothing herein shall limit a Holder&rsquo;s
right to pursue any other remedies available to it hereunder, at law or in equity including, without limitation, a decree of specific
performance and/or injunctive relief with respect to the Corporation&rsquo;s failure to timely deliver certificates representing shares
of Common Stock upon conversion of the shares of Series&nbsp;X Preferred Stock as required pursuant to the terms hereof; provided, however,
that the Holder shall not be entitled to both (i)&nbsp;require the reissuance of the shares of Series&nbsp;X Preferred Stock submitted
for conversion for which such conversion was not timely honored and (ii)&nbsp;receive the number of shares of Common Stock that would
have been issued if the Corporation had timely complied with its delivery requirements under Section&nbsp;6(d)(i).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Reservation
of Shares Issuable Upon Conversion</U>. The Corporation covenants that it will at all times reserve and keep available out of its authorized
and unissued shares of Common Stock for the sole purpose of issuance upon conversion of the Series&nbsp;X Preferred Stock, free from preemptive
rights or any other actual contingent purchase rights of Persons other than the Holders of the Series&nbsp;X Preferred Stock, not less
than such aggregate number of shares of the Common Stock as shall be issuable (taking into account the adjustments of Section&nbsp;7)
upon the conversion of all outstanding shares of Series&nbsp;X Preferred Stock. The Corporation covenants that all shares of Common Stock
that shall be so issuable shall, upon issue, be duly authorized, validly issued, fully paid and non-assessable.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Fractional
Shares</U>. No fractional shares or scrip representing fractional shares of Common Stock shall be issued upon the conversion of the Series&nbsp;X
Preferred Stock. As to any fraction of a share which a Holder would otherwise be entitled to receive upon such conversion, the Corporation
shall pay a cash adjustment in respect of such final fraction in an amount equal to such fraction multiplied by the Conversion Price.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Transfer
Taxes</U>. The issuance of certificates for shares of the Common Stock upon conversion of the Series&nbsp;X Preferred Stock shall be made
without charge to any Holder for any documentary stamp or similar taxes that may be payable in respect of the issue or delivery of such
certificates, provided that the Corporation shall not be required to pay any tax that may be payable in respect of any transfer involved
in the issuance and delivery of any such certificate upon conversion in a name other than that of the registered Holder(s)&nbsp;of such
shares of Series&nbsp;X Preferred Stock and the Corporation shall not be required to issue or deliver such certificates unless or until
the Person or Persons requesting the issuance thereof shall have paid to the Corporation the amount of such tax or shall have established
to the satisfaction of the Corporation that such tax has been paid.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Status
as Stockholder</U>. Upon each Conversion Date: (i)&nbsp;the shares of Series&nbsp;X Preferred Stock being converted shall be deemed converted
into shares of Common Stock; and (ii)&nbsp;the Holder&rsquo;s rights as a holder of such converted shares of Series&nbsp;X Preferred Stock
shall cease and terminate, excepting only the right to receive certificates for such shares of Common Stock and to any remedies provided
herein or otherwise available at law or in equity to such Holder because of a failure by the Corporation to comply with the terms of this
Certificate of Designation. In all cases, the holder shall retain all of its rights and remedies for the Corporation&rsquo;s failure to
convert Series&nbsp;X Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Section&nbsp;7</U></FONT><FONT STYLE="font-size: 10pt">.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Certain
Adjustments</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Stock
Dividends and Stock Splits</U>. If the Corporation, at any time while this Series&nbsp;X Preferred Stock is outstanding: (A)&nbsp;pays
a stock dividend or otherwise makes a distribution or distributions payable in shares of Common Stock (which, for avoidance of doubt,
shall not include any shares of Common Stock issued by the Corporation upon conversion of this Series&nbsp;X Preferred Stock) with respect
to the then outstanding shares of Common Stock; (B)&nbsp;subdivides outstanding shares of Common Stock into a larger number of shares;
or (C)&nbsp;combines (including by way of a reverse stock split) outstanding shares of Common Stock into a smaller number of shares, then
the Conversion Price shall be multiplied by a fraction of which the numerator shall be the number of shares of Common Stock (excluding
any treasury shares of the Corporation) outstanding immediately before such event and of which the denominator shall be the number of
shares of Common Stock outstanding immediately after such event (excluding any treasury shares of the Corporation). Any adjustment made
pursuant to this Section&nbsp;7(a)&nbsp;shall become effective immediately after the record date for the determination of stockholders
entitled to receive such dividend or distribution and shall become effective immediately after the effective date in the case of a subdivision
or combination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Fundamental
Transaction</U>. If, at any time while this Series&nbsp;X Preferred Stock is outstanding and other than in connection with a Liquidation
Event or a Deemed Liquidation Event (but including any event that was deemed to not constitute a Deemed Liquidation Event by a vote of
the holders of a majority of the Series&nbsp;X Preferred), (A)&nbsp;the Corporation effects any merger or consolidation of the Corporation
with or into another Person or any stock sale to, or other business combination (including, without limitation, a reorganization, recapitalization,
spin-off, share exchange or scheme of arrangement) with or into another Person (other than such a transaction in which the Corporation
is the surviving or continuing entity and its Common Stock is not exchanged for or converted into other securities, cash or property),
(B)&nbsp;the Corporation effects any sale, lease, transfer or exclusive license of all or substantially all of its assets in one transaction
or a series of related transactions, (C)&nbsp;any tender offer or exchange offer (whether by the Corporation or another Person) is completed
pursuant to which more than 50% of the Common Stock not held by the Corporation or such Person is exchanged for or converted into other
securities, cash or property, or (D)&nbsp;the Corporation effects any reclassification of the Common Stock or any compulsory share exchange
pursuant (other than as a result of a dividend, subdivision or combination covered by Section&nbsp;7(a)&nbsp;above) to which the Common
Stock is effectively converted into or exchanged for other securities, cash or property (in any such case, a &ldquo;<B><U>Fundamental
Transaction</U></B>&rdquo;), then, upon any subsequent conversion of this Series&nbsp;X Preferred Stock the Holders shall have the right
to receive, in lieu of the right to receive Conversion Shares, for each Conversion Share that would have been issuable upon such conversion
immediately prior to the occurrence of such Fundamental Transaction, the same kind and amount of securities, cash or property as it would
have been entitled to receive upon the occurrence of such Fundamental Transaction if it had been, immediately prior to such Fundamental
Transaction, the holder of one share of Common Stock (the &ldquo;<B><U>Alternate Consideration</U></B>&rdquo;). For purposes of any such
subsequent conversion, the determination of the Conversion Ratio shall be appropriately adjusted to apply to such Alternate Consideration
based on the amount of Alternate Consideration issuable in respect of one share of Common Stock in such Fundamental Transaction, and the
Corporation shall adjust the Conversion Ratio in a reasonable manner reflecting the relative value of any different components of the
Alternate Consideration. If holders of Common Stock are given any choice as to the securities, cash or property to be received in a Fundamental
Transaction, then the Holders shall be given the same choice as to the Alternate Consideration it receives upon any conversion of this
Series&nbsp;X Preferred Stock following such Fundamental Transaction. To the extent necessary to effectuate the foregoing provisions,
any successor to the Corporation or surviving entity in such Fundamental Transaction shall file a new certificate of designation with
the same terms and conditions and issue to the Holders new preferred stock consistent with the foregoing provisions and evidencing the
Holders&rsquo; right to convert such preferred stock into Alternate Consideration. The terms of any agreement to which the Corporation
is a party and pursuant to which a Fundamental Transaction is effected shall include terms requiring any such successor or surviving entity
to comply with the provisions of this Section&nbsp;7(b)&nbsp;and insuring that this Series&nbsp;X Preferred Stock (or any such replacement
security) will be similarly adjusted upon any subsequent transaction analogous to a Fundamental Transaction. The Corporation shall cause
to be delivered to each Holder, at its last address as it shall appear upon the stock books of the Corporation, written notice of any
Fundamental Transaction at least 20 calendar days prior to the date on which such Fundamental Transaction is expected to become effective
or close.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Calculations</U>.
All calculations under this Section&nbsp;7 shall be made to the nearest cent or the nearest 1/100th of a share, as the case may be. For
purposes of this Section&nbsp;7, the number of shares of Common Stock deemed to be issued and outstanding as of a given date shall be
the sum of the number of shares of Common Stock (excluding any treasury shares of the Corporation) issued and outstanding.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Notice
to the Holders</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Adjustment
to Conversion Price</U>. Whenever the Conversion Price is adjusted pursuant to any provision of this Section&nbsp;7, the Corporation shall
promptly deliver to each Holder a notice setting forth the Conversion Ratio after such adjustment and setting forth a brief statement
of the facts requiring such adjustment.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Other
Notices</U>. If (A)&nbsp;the Corporation shall declare a dividend (or any other distribution in whatever form) on the Common Stock, (B)&nbsp;the
Corporation shall declare a special nonrecurring cash dividend on the Common Stock, (C)&nbsp;the Corporation shall authorize the granting
to all holders of the Common Stock of rights or warrants to subscribe for or purchase any shares of capital stock of any class or of any
rights, (D)&nbsp;the approval of any stockholders of the Corporation shall be required in connection with any reclassification of the
Common Stock, any consolidation or merger to which the Corporation is a party, any sale or transfer of all or substantially all of the
assets of the Corporation, or any compulsory share exchange whereby the Common Stock is converted into other securities, cash or property,
or (E)&nbsp;the Corporation shall authorize the voluntary or involuntary dissolution, liquidation or winding up of the affairs of the
Corporation, then, in each case, the Corporation shall cause to be filed at each office or agency maintained for the purpose of conversion
of this Series&nbsp;X Preferred Stock, and shall cause to be delivered to each Holder at its last address as it shall appear upon the
stock books of the Corporation, at least 20 calendar days prior to the applicable record or effective date hereinafter specified, a notice
stating (x)&nbsp;the date on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants,
or if a record is not to be taken, the date as of which the holders of the Common Stock of record to be entitled to such dividend, distributions,
redemption, rights or warrants are to be determined or (y)&nbsp;the date on which such reclassification, consolidation, merger, sale,
transfer or share exchange is expected to become effective or close, and the date as of which it is expected that holders of the Common
Stock of record shall be entitled to exchange their shares of the Common Stock for securities, cash or other property deliverable upon
such reclassification, consolidation, merger, sale, transfer or share exchange, provided that the failure to deliver such notice or any
defect therein or in the delivery thereof shall not affect the validity of the corporate action required to be specified in such notice.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Redemption</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>General</U>.
Unless prohibited by Delaware law governing distributions to stockholders, shares of Series&nbsp;X Preferred Stock shall be redeemed by
the Corporation at a price equal to the Stated Value, plus all declared but unpaid dividends thereon (the &ldquo;<B><U>Redemption Price</U></B>&rdquo;)
subject to the terms and conditions set forth in this Section&nbsp;8. Redemptions of Series&nbsp;X Preferred Stock (if any) shall occur
within a 90-day period following the Corporation&rsquo;s delivery of a written notice to the Holders of the sale of all or substantially
of the Corporations assets relating to the Corporation&rsquo;s dialysis concentrates business line (a &ldquo;<B><U>Concentrates Divestiture</U></B>&rdquo;).
The Corporation shall be required to provide written notice of a Concentrates Divestiture within 10 calendar days from completion of the
sale (a &ldquo;<B><U>Disposition Notice</U></B>&rdquo;). Following delivery of the Disposition Notice, holders of Series&nbsp;X Preferred
Stock will have a 30-day period to submit to the Corporation a written notice requesting redemption of shares of Series&nbsp;X Preferred
Stock held by such stockholder (the &ldquo;<B><U>Redemption Request</U></B>&rdquo;). Upon receipt of a Redemption Request, the requested
shares of Series&nbsp;X Preferred Stock shall be subject to redemption under this Section&nbsp;8(a)&nbsp;on the 90<SUP>th</SUP> day thereafter,
or such earlier date as selected by the Corporation (the &ldquo;<B><U>Redemption Date</U></B>&rdquo;). Notwithstanding anything herein
to the contrary, the aggregate value of the Redemption Price shall not exceed the proceeds from the Concentrates Divestiture, after subtracting
any repayment of indebtedness that is secured (in whole or in part) by the transferred assets. If, on the Redemption Date, Delaware law
governing distributions to stockholders or the immediately preceding sentence prevents the Corporation from redeeming all shares of Series&nbsp;X
Preferred Stock to be redeemed, the Corporation shall ratably redeem the maximum number of shares that it may redeem consistent with such
law, and shall redeem the remaining shares as soon as it may lawfully do so under such law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Redemption
Notice</U>. The Corporation shall send written notice of the mandatory redemption (the &ldquo;<B><U>Redemption Notice</U></B>&rdquo;)
to each holder of record of Series&nbsp;X Preferred Stock not less than 30 calendar days prior to the Redemption Date. The Redemption
Notice shall state:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
number of shares of Series&nbsp;X Preferred Stock held by the holder that the Corporation shall redeem on the Redemption Date specified
in the Redemption Notice;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT>&#8239;&#8239;<FONT STYLE="font-size: 10pt">the
Redemption Date and the Redemption Price; and</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in">(iii)&#8239;for holders of shares in
certificated form, that the holder is to surrender to the Corporation, in the manner and at the place designated, his, her or its certificate
or certificates representing the shares of Series&nbsp;X Preferred Stock to be redeemed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">If the Corporation receives, on or prior to the
twentieth (20th) day after the date of delivery of the Redemption Notice to a holder of Series&nbsp;X Preferred Stock, written notice
from such holder that such holder elects to be excluded from the redemption provided in this Section&nbsp;8, then the shares of Series&nbsp;X
Preferred Stock registered on the books of the Corporation in the name of such holder at the time of the Corporation&rsquo;s receipt of
such notice shall thereafter be &ldquo;<B>Excluded Shares</B>.&rdquo; Excluded Shares shall not be redeemed or redeemable pursuant to
this Section&nbsp;8, whether on such Redemption Date or thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Surrender
of Certificates; Payment</U>. On or before the Redemption Date, each holder of shares of Series&nbsp;X Preferred Stock to be redeemed
on the Redemption Date, unless such holder has exercised his, her or its right to convert such shares as provided in Section&nbsp;6, shall,
if a holder of shares in certificated form, surrender the certificate or certificates representing such shares (or, if such registered
holder alleges that such certificate has been lost, stolen or destroyed, a lost certificate affidavit and agreement reasonably acceptable
to the Corporation to indemnify the Corporation against any claim that may be made against the Corporation on account of the alleged loss,
theft or destruction of such certificate) to the Corporation, in the manner and at the place designated in the Redemption Notice, and
thereupon the Redemption Price for such shares shall be payable to the order of the person whose name appears on such certificate or certificates
as the owner thereof. In the event less than all of the shares of Series&nbsp;X Preferred Stock represented by a certificate are redeemed,
a new certificate, instrument, or book entry representing the unredeemed shares of Series&nbsp;X Preferred Stock shall promptly be issued
to such holder.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Rights
Subsequent to Redemption</U>. If the Redemption Notice shall have been duly given, and if on the applicable Redemption Date the Redemption
Price payable upon redemption of the shares of Series&nbsp;X Preferred Stock to be redeemed on such Redemption Date is paid or tendered
for payment or deposited with an independent payment agent so as to be available therefor in a timely manner, then notwithstanding that
any certificates evidencing any of the shares of Series&nbsp;X Preferred Stock so called for redemption shall not have been surrendered,
dividends with respect to such shares of Series&nbsp;X Preferred Stock shall cease to accrue after such Redemption Date and all rights
with respect to such shares shall forthwith after the Redemption Date terminate, except only the right of the holders to receive the Redemption
Price without interest upon surrender of any such certificate or certificates therefor.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Redeemed
or Otherwise Acquired Shares</U>. Any shares of Series&nbsp;X Preferred Stock that are redeemed, converted or otherwise acquired by the
Corporation or any of its subsidiaries shall be automatically and immediately cancelled and retired and shall not be reissued, sold or
transferred. Neither the Corporation nor any of its subsidiaries may exercise any voting or other rights granted to the holders of Series&nbsp;X
Preferred Stock following redemption, conversion or acquisition.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>9</U></FONT><FONT STYLE="font-size: 10pt">.</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Miscellaneous</U>.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Notices</U>.
Any and all notices or other communications or deliveries to be provided by the Holders hereunder including, without limitation, any Notice
of Conversion, shall be in writing and delivered personally, by facsimile, via email, or sent by a nationally recognized overnight courier
service, addressed to the Corporation, at such facsimile number, email address, or mailing address as the Corporation may specify for
such purposes by notice to the Holders delivered in accordance with this Section. Any and all notices or other communications or deliveries
to be provided by the Corporation hereunder shall be in writing and delivered personally, by facsimile, email, or sent by a nationally
recognized overnight courier service addressed to each Holder at the facsimile number, email address or mailing address of such Holder
appearing on the books of the Corporation, or if no such facsimile number, email address, or mailing address appears on the books of the
Corporation, at the principal place of business of such Holder. Any notice or other communication or deliveries hereunder shall be deemed
given and effective on the earliest of: (i)&nbsp;the date of transmission, if such notice or communication is delivered via facsimile
or email prior to 5:30 p.m.&nbsp;(New York City time) on any date, (ii)&nbsp;the date immediately following the date of transmission,
if such notice or communication is delivered via facsimile or email between 5:30 p.m.&nbsp;and 11:59 p.m.&nbsp;(New York City time) on
any date, (iii)&nbsp;the second Business Day following the date of mailing, if sent by nationally recognized overnight courier service,
or (iv)&nbsp;upon actual receipt by the party to whom such notice is required to be given.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Lost
or Mutilated Series&nbsp;X Preferred Stock Certificate</U>. If a Holder&rsquo;s Series&nbsp;X Preferred Stock certificate shall be mutilated,
lost, stolen or destroyed, the Corporation shall execute and deliver, in exchange and substitution for and upon cancellation of a mutilated
certificate, or in lieu of or in substitution for a lost, stolen or destroyed certificate, a new certificate for the shares of Series&nbsp;X
Preferred Stock so mutilated, lost, stolen or destroyed, but only upon receipt of evidence of such loss, theft or destruction of such
certificate, and of the ownership thereof, reasonably satisfactory to the Corporation and, in each case, customary and reasonable indemnity,
if requested. Applicants for a new certificate under such circumstances shall also comply with such other reasonable regulations and procedures
and pay such other reasonable third-party costs as the Corporation may prescribe.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Waiver</U>.
Any waiver by the Corporation or a Holder of a breach of any provision of this Certificate of Designation shall not operate as or be construed
to be a waiver of any other breach of such provision or of any breach of any other provision of this Certificate of Designation or a waiver
by any other Holders. The failure of the Corporation or a Holder to insist upon strict adherence to any term of this Certificate of Designation
on one or more occasions shall not be considered a waiver or deprive that party (or any other Holder) of the right thereafter to insist
upon strict adherence to that term or any other term of this Certificate of Designation. Any waiver by the Corporation or a Holder must
be in writing. Notwithstanding any provision in this Certificate of Designation to the contrary, any provision contained herein and any
right of the Holders of Series&nbsp;X Preferred Stock granted hereunder may be waived as to all shares of Series&nbsp;X Preferred Stock
(and the Holders thereof) upon the written consent of the Holders of not less than a majority of the shares of Series&nbsp;X Preferred
Stock then outstanding, unless a higher percentage is required by the DGCL, in which case the written consent of the Holders of not less
than such higher percentage shall be required.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Severability</U>.
If any provision of this Certificate of Designation is invalid, illegal or unenforceable, the balance of this Certificate of Designation
shall remain in effect, and if any provision is inapplicable to any Person or circumstance, it shall nevertheless remain applicable to
all other Persons and circumstances. If it shall be found that any interest or other amount deemed interest due hereunder violates the
applicable law governing usury, the applicable rate of interest due hereunder shall automatically be lowered to equal the maximum rate
of interest permitted under applicable law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Next
Business Day</U>. Whenever any payment or other obligation hereunder shall be due on a day other than a Business Day, such payment shall
be made on the next succeeding Business Day.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)</FONT>&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Headings</U>.
The headings contained herein are for convenience only, do not constitute a part of this Certificate of Designation and shall not be deemed
to limit or affect any of the provisions hereof.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)</FONT>&#8239;&#8239;&#8239;<FONT STYLE="font-size: 10pt"><U>Status
of Converted Series&nbsp;X Preferred Stock</U>. If any shares of Series&nbsp;X Preferred Stock shall be converted or reacquired by the
Corporation, such shares shall resume the status of authorized but unissued shares of preferred stock and shall no longer be designated
as Series&nbsp;X Preferred Stock.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">********************</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>IN
WITNESS WHEREOF</B></FONT>, the undersigned has executed this Certificate of Designation this 7th day of April, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; width: 50%">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; text-align: left; font-size: 10pt; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Russell Skibsted</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Russell Skibsted, Chief Financial Officer</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>ANNEX A</B></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">NOTICE OF CONVERSION</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(TO BE EXECUTED BY THE REGISTERED HOLDER<BR>
IN ORDER TO CONVERT SHARES OF SERIES X PREFERRED STOCK)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">The undersigned
Holder hereby irrevocably elects to convert the number of shares of Series&nbsp;X Preferred Stock indicated below, represented by stock
certificate No(s). [_____] (the </FONT>&ldquo;<B><U>Preferred Stock Certificates</U></B>&rdquo;), into shares of common stock, par value
$0.0001 per share (the &ldquo;<B><U>Common Stock</U></B>&rdquo;), of Rockwell Medical,&nbsp;Inc., a Delaware corporation (the &ldquo;<B><U>Corporation</U></B>&rdquo;),
as of the date written below. If securities are to be issued in the name of a person other than the undersigned, the undersigned will
pay all transfer taxes payable with respect thereto. Capitalized terms utilized but not defined herein shall have the meaning ascribed
to such terms in that certain Certificate of Designation of Preferences, Rights and Limitations of Series&nbsp;X Convertible Preferred
Stock (the &ldquo;<B><U>Certificate of Designation</U></B>&rdquo;) filed by the Corporation with the Secretary of State of the State of
Delaware on April&nbsp;7, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">As of the
date hereof, the number of shares of Common Stock beneficially owned by the undersigned Holder (together with such Holder</FONT>&rsquo;s
Affiliates, and any other Person whose beneficial ownership of Common Stock would be aggregated with the Holder&rsquo;s for purposes of
Section&nbsp;13(d)&nbsp;or Section&nbsp;16 of the Exchange Act and the applicable regulations of the Commission, including any &ldquo;group&rdquo;
of which the Holder is a member (the foregoing, &ldquo;<B><U>Attribution Parties</U></B>&rdquo;)), including the number of shares of Common
Stock issuable upon conversion of the Series&nbsp;X Preferred Stock subject to this Notice of Conversion, but excluding the number of
shares of Common Stock which are issuable upon (A)&nbsp;conversion of the remaining, unconverted Series&nbsp;X Preferred Stock beneficially
owned by such Holder or any of its Attribution Parties, and (B)&nbsp;exercise or conversion of the unexercised or unconverted portion
of any other securities of the Corporation (including any warrants) beneficially owned by such Holder or any of its Attribution Parties
that are subject to a limitation on conversion or exercise similar to the limitation contained in Section&nbsp;6(c)&nbsp;of the Certificate
of Designation, is 9.9%. For purposes hereof, beneficial ownership shall be calculated in accordance with Section&nbsp;13(d)&nbsp;of the
Exchange Act and the applicable regulations of the Commission. In addition, for purposes hereof, &ldquo;group&rdquo; has the meaning set
forth in Section&nbsp;13(d)&nbsp;of the Exchange Act and the applicable regulations of the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Conversion calculations:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR>
    <TD COLSPAN="11">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="12">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="11" STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date to Effect Conversion: </FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="12" STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="19">&nbsp;</TD>
    <TD COLSPAN="5">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="19" STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of shares of Series&nbsp;X Preferred Stock owned prior to Conversion: </FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="4" STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="17">&nbsp;</TD>
    <TD COLSPAN="7">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="17" STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of shares of Series&nbsp;X Preferred Stock to be Converted: </FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="15">&nbsp;</TD>
    <TD COLSPAN="9">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="15" STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Number of shares of Common Stock to be Issued: </FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="8" STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="13">&nbsp;</TD>
    <TD COLSPAN="11">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="13" STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Address for delivery of physical certificates: </FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="13" STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>or</U></FONT></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="vertical-align: top">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="7">&nbsp;</TD>
    <TD COLSPAN="17">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="7" STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">for DWAC Delivery: </FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="15" STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="7">&nbsp;</TD>
    <TD COLSPAN="15">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD COLSPAN="7" STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DWAC Instructions: </FONT></TD>
    <TD COLSPAN="2" STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="13" STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD>
    <TD COLSPAN="17">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD COLSPAN="3" STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Broker no: </FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="16" STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="3">&nbsp;</TD>
    <TD COLSPAN="18">&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="3" STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Account no: </FONT></TD>
    <TD STYLE="vertical-align: bottom; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="17" STYLE="vertical-align: top; border-bottom: black 1pt solid">&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 10%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 7%">&nbsp;</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 41%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 1%">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HOLDER</FONT></TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; vertical-align: top">
</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; width: 42%">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

<!-- Field: Page; Sequence: 18; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>rmti-20220406.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaqAGbOdzZR+GYkxtmB6bZmaryYsoaBvlCpZd6VWIXkP -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:rmti="http://rockwellmed.com/20220406" elementFormDefault="qualified" targetNamespace="http://rockwellmed.com/20220406">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://rockwellmed.com/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="rmti-20220406_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="rmti-20220406_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>rmti-20220406_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>rmti-20220406_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.12c -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://rockwellmed.com/role/Cover" xlink:href="rmti-20220406.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://rockwellmed.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm140475635851960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 06, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr.  06,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-23661<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Rockwell Medical, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001041024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">38-3317208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">30142
S. Wixom Road<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Wixom, Michigan
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">48393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">248<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">960-9009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RMTI<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>tm2212215d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rmti-20220406.xsd" xlink:type="simple"/>
    <context id="From2022-04-06to2022-04-06">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001041024</identifier>
        </entity>
        <period>
            <startDate>2022-04-06</startDate>
            <endDate>2022-04-06</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2022-04-06to2022-04-06">0001041024</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2022-04-06to2022-04-06">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="From2022-04-06to2022-04-06">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="From2022-04-06to2022-04-06">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2022-04-06to2022-04-06">2022-04-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2022-04-06to2022-04-06">Rockwell Medical, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2022-04-06to2022-04-06">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2022-04-06to2022-04-06">000-23661</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2022-04-06to2022-04-06">38-3317208</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2022-04-06to2022-04-06">30142 S. Wixom Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2022-04-06to2022-04-06">Wixom, Michigan </dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2022-04-06to2022-04-06">MI</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2022-04-06to2022-04-06">48393</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2022-04-06to2022-04-06">248</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2022-04-06to2022-04-06">960-9009</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2022-04-06to2022-04-06">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2022-04-06to2022-04-06">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2022-04-06to2022-04-06">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2022-04-06to2022-04-06">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2022-04-06to2022-04-06">Common Stock, par value $0.0001</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2022-04-06to2022-04-06">RMTI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2022-04-06to2022-04-06">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2022-04-06to2022-04-06">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MN@-==3Q.'P=&IOD1=BT-'(CSRQUGL 7L"_!\(Z5Y']A3<?%/C=&_4$L#!!0
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M8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ %86(5)E<G",0!@  G"<  !,
M             ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M"  5A8A4"UJ02EX$  #@$   &               @($."   >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ %86(5)^@&_"Q @  X@P   T
M             ( !H@P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  5A8A4
MEXJ[',     3 @  "P              @ %^#P  7W)E;',O+G)E;'-02P$"
M% ,4    "  5A8A4JL0B%C,!   B @  #P              @ %G$   >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ %86(5"0>FZ*M    ^ $  !H
M         ( !QQ$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ %86(5&60>9(9 0  SP,  !,              ( !K!(  %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ]A,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2212215d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://rockwellmed.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2212215d1_8k.htm">tm2212215d1_8k.htm</File>
    <File>rmti-20220406.xsd</File>
    <File>rmti-20220406_lab.xml</File>
    <File>rmti-20220406_pre.xml</File>
    <File>tm2212215d1_ex3-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2212215d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "tm2212215d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rmti-20220406_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rmti-20220406_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "rmti-20220406.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "rmti",
   "nsuri": "http://rockwellmed.com/20220406",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2212215d1_8k.htm",
      "contextRef": "From2022-04-06to2022-04-06",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://rockwellmed.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2212215d1_8k.htm",
      "contextRef": "From2022-04-06to2022-04-06",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://rockwellmed.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001104659-22-044286-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-22-044286-xbrl.zip
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ML7\"'RB.\A^);0-97AH--],TR[]02P,$%     @ %86(5-^\/<?_"@  ;(<
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MG5LN )MM,#110&38G0%H5&)4J)&0>X/CEB=;S%^72=33;9A"MWA 1MM\Z*J
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M2N>A2$/L'DUG?UK_&:DH#PA<LQ7'<E';Y>MVS5)@)2RKRA4('185"Q9)$#C
MOG0BKAFJI*C4^EHIJV784B0MW14$5ENJ^EN)052\S9'1"+3JVV/S?[&/'H0Q
M DQVL,M<=P,VDWI7T-0$@4&',>-DI9(BI?4UV>'0A6WZ!P4;;X."3<^@8!/B
MH& S=%"P\3HH4+LNERD1;=3-.DTV&%@TL5/M&HP.RSHC%FE0N,#^P+:C#D&'
M&!^K;1;+KLE7"?!MX>%2?+"4%- Y6V^SRV:]X*9-% 0G7<Z,)3?+A? :8B35
M/MC8Q4E.XM+094(QC1*<UDLWVJZ>]X<X(V:@^1J>'GT8' TS:2!5AJDU%NO
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M,+8S\*:(<2SU=L0,8\"TG&H-L'E1*2O;&2YSC&KPF^ _AY[N&:QRF!>_X>V
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MV&NAGCIQK %R8%8I9Y5MSYI^SA 35@U3,7T_D<<RE2F3'>8C4_S*K$)IO\N
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M]X[UF+'5($R8CW)Y@D<%Z^ERG/S#%[:I*$H2$OC2 S1QGV2JJN(H20.%>UV
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MPS.:X>FWG-'QVV_Y]M.#D\.#T^ ?P=[QT=]Q"]^\/Y#-.CG8A[G :6N?7W/
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M,*LZ2^.2G[JPK*$J2&/4^8U9I(:P#:*.74+FYD6F44Y?)66,FNE5@6DI&=I
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M6I?4#ZW=87H9):DVO^Q!E2UDNUS)$%& 8%;[+FVP(#R;]7T=U6^X;"V_)IY
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M@9&Z>U/7T(22BQSZ;&(N\RS8N+;<!Y^Q?K1\%=:NN3A;\$79,N\,Z^(655(
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MZ+KC25#.BMDCYG93V+%.M1 C. 1\\<#H;@Q[]D>$7,$R@:[H@RX\=:4Y$C=
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MXH*M',;XU:4Y:GNQ32?O$'9[(TY!8"/1C!'K0Y=QJ<FW< _RK-K:0!E7!(S
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MQ_O_),G\[NRW]Z__/U!+ 0(4 Q0    ( !6%B%2SI_MU/ ,  /X+   1
M          "  0    !R;71I+3(P,C(P-# V+GAS9%!+ 0(4 Q0    ( !6%
MB%3?O#W'_PH  &R'   5              "  6L#  !R;71I+3(P,C(P-# V
M7VQA8BYX;6Q02P$"% ,4    "  5A8A4IM6SQ%@'  #'6   %0
M    @ &=#@  <FUT:2TR,#(R,#0P-E]P<F4N>&UL4$L! A0#%     @ %86(
M5%((B4CR&@  ?I,  !(              ( !*!8  '1M,C(Q,C(Q-60Q7SAK
M+FAT;5!+ 0(4 Q0    ( !6%B%3->3XA4T<  />H 0 5              "
M 4HQ  !T;3(R,3(R,35D,5]E>#,M,2YH=&U02P4&      4 !0!( 0  T'@
#

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
